A weekend/weekday comparison of adherence to daily treatment regimens in adults with cystic fibrosis by Keyte, Rebecca et al.
health psychology report · 8
original article
background
Treatment adherence is a major concern in cystic fibrosis 
(CF), with accumulating evidence that health outcomes 
are worse in patients with lower levels of adherence. This 
study investigates how adherence differs for adults with 
CF during a  weekday and a  weekend day by examining 
the roles of sex, anxiety, depression, and lung function as 
predictors of adherence.
participants and procedure
Fifty-two adult participants with CF were recruited. De-
mographics and spirometry results were recorded. Par-
ticipants completed the Hospital Anxiety and Depression 
Scale and two daily phone diaries in order to record their 
adherence to pancreatic enzymes, vitamins, physiotherapy 
and exercise. Based on previous findings, it was hypothe-
sised that reported adherence would be higher during the 
weekend in comparison to weekdays, due to lower time 
pressure during the weekend.
results
Paired sample t-tests indicated that overall participants 
had higher reported adherence during the weekend in 
comparison to weekdays, with sex, anxiety, depression and 
lung function being predictors of adherence.
conclusions
Clinical implications and future directions are discussed, 
with an emphasis on the need for further qualitative re-
search. We are now conducting another research project 
utilising qualitative interviews with participants to further 
investigate adherence within the CF population. Our aim 
is to identify the main adherence barriers and to develop 
interventions to improve treatment adherence in the CF 
population.
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Background
The increased life expectancy for people with CF is 
creating a  welcome challenge for health care pro-
fessionals in supporting adolescent patients as they 
become increasingly responsible for their own med-
ical regimens (Bregnballe, Schiotz, Boisen, Pressler, 
& Thastum, 2011). The challenges for CF patients are 
manifold in independently maintaining their com-
plex and time-consuming daily treatment regimens, 
involving medication (e.g. pancreatic enzymes, vita-
mins), physiotherapy and exercise (Barker, Driscoll, 
Modi, Light, &  Quittner, 2012). Ongoing treatment 
adherence is a  major concern within the CF popu-
lation (Horne, 2000); with Eakin, Bilderback, Boyle, 
Mogayzel, and Riekert (2011), demonstrating that 
poor adherence is a  significant predictor of pulmo-
nary exacerbations during a  12-month period. Fur-
thermore, Quittner et al. (2014) indicated through the 
use of medication progression ratios how adherence 
to long-term pulmonary medications are significant 
predictors of subsequent health-care use and costs, 
with poor adherence being associated with acute 
health-care. Therefore effort needs to be made to im-
prove treatment adherence within the CF population, 
by creating an intervention for clinicians to imple-
ment to promote adherence, thus improving subse-
quent health outcomes (Eakin et al., 2011). In order to 
create such an intervention, factors associated with 
adherence need to be more clearly identified.
Research evidence indicates that adherence with-
in CF differs between treatment types, with adher-
ence to physiotherapy and vitamins being lower than 
adherence to pancreatic enzymes and exercise (Ab-
bott, Dodd, Bilton, & Webb, 1994). Abbott et al. (1994) 
suggest that this may be because patients prioritise 
short-term treatment benefits, with less consider-
ation for long-term benefits. This previous research 
did not investigate adherence to inhaled therapies 
(e.g. mucolytics and antibiotics), but it is important to 
recognise that many patients view inhaled therapies 
as being distinct from physiotherapy. 
There are a  number of factors that have been 
identified in the literature as having an impact on 
adherence success. Limited positive reinforcement, 
as health may deteriorate despite adherence efforts 
(Kettler et al., 2002), the challenge of fitting complex 
regimens into daily routine (Horne, Weinman, Barber, 
Elliot, & Morgan, 2006), and time pressures have been 
identified as relevant determinants of adherence. 
Much of the focus in research has been around time 
pressures. McNamara, McCormack, McDonald, Heaf, 
and Southern (2009) demonstrated that children with 
CF are more adherent to nebulised therapies in the 
evenings in comparison to the mornings, suggesting 
greater time pressures in the mornings (for both par-
ents and children) (Latchford, Duff, Quinn, Conway, 
& Conner, 2009; McNamara et al., 2009). This is sup-
ported by Bregnballe et al.’s work (2011), with 60.00% 
of CF adolescents agreeing that one of the main ad-
herence barriers is a  lack of time. Ball et al. (2013) 
examined weekday/weekend and term-time/holiday 
adherence to nebulised therapies in adolescents with 
CF over an academic year. Within this research ad-
herence was shown to be higher during weekdays in 
comparison to weekends, and during term times in 
comparison to holidays, demonstrating the impor-
tance of integrating CF care into “structured, daily 
family schedules, which act to contain treatments” 
(Horne et al., 2006). Ball et al.’s (2013) findings may 
not be replicated in an adult CF population, as there 
may be discrepancies between the time pressures ex-
perienced by adult and paediatric patients. 
Research investigating adherence within CF has 
identified the roles of anxiety, depression and dis-
ease severity as predictors of adherence. Kettler et 
al. (2002) suggest that an increase in disease sever-
ity may be associated with a decrease in adherence. 
However, Abbott et al. (1994) found no association 
between disease severity and adherence in an earlier 
study, and this was confirmed by Daniels et al. (2011) 
using electronic monitoring data. A concomitant in-
crease in psychological distress may also account for 
a reduction in adherence (Kilbourne, 2005; Sundbom 
&  Bingefors, 2013). Hillard, Eakin, Borrelli, Green, 
and Riekert (2014) concluded that higher depressive 
symptoms within CF patients are associated with less 
positive medication beliefs, which is associated with 
lower medication adherence, demonstrating the need 
to monitor depressive symptoms within CF patients 
to help identify risks for non-adherence. In contrast, 
research has suggested that people with CF who have 
concerns and anxieties about their health are moti-
vated to adhere to their treatments, with such con-
cerns surrounding CF’s life-threatening status, and 
the uncertain future this brings, with some people 
describing how health deterioration can exacerbate 
their concerns (Keyte et al., 2017). Backström-Eriks-
son, Sorjonen, Bergsten-Brucefors, Hjelte, and Melin 
(2015) suggested that there is no elevated risk for 
anxiety or depression amongst CF patients.
Sex differences in adherence have also been 
demonstrated to be important within the CF popula-
tion (Abbott, Havermans, & Hart, 2009), with female 
adolescents with CF displaying more non-adherent 
behaviours and attitudes than male adolescents with 
CF (Patterson, Wall, Berge, & Milla, 2008). These dif-
ferences were most evident for behaviours that were 
visible to peers (embarrassment about coughing, 
skipping medications), which could contribute to 
self-consciousness (Patterson et al., 2008). 
Despite advances in the understanding of factors 
that potentially predict adherence, adherence with-
in CF is still poorly understood. Adherence rates 
vary across studies, due to the variety of different 
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methodologies used and the limitations of these 
methodologies (Kettler et al., 2002). As self-report-
ed measures often inflate rates of adherence, there 
is a  need to investigate methodologies that are ac-
curate and reliable (Modi et al., 2006; O’Donohoe 
& Fullen, 2014). Electronic data collection methods, 
for instance nebulisers which directly record adher-
ence to nebulised treatment (Daniels et al., 2011), 
are the “gold standard”, but this technology cannot 
currently be used to assess adherence to tablet treat-
ments and chest physiotherapy. One methodology 
which attempts to address some of these limitations 
is the Daily Phone Diary (DPD). Modi et al. (2006) 
found that DPDs did not inflate rates of adherence (in 
contrast to self-report measures), and that the DPD 
methodology provides a more objective measure of 
adherence for certain treatment modalities, in com-
parison to self-report measures. Several adherence 
studies have utilised DPDs, with researchers con-
cluding that this method demonstrates good reliabil-
ity and validity when recording adherence within CF 
(Modi & Quittner, 2006; Quittner & Espelage, 1999). 
This study aimed to investigate how adherence 
to pancreatic enzymes, vitamins, physiotherapy and 
exercise differs for CF adults during a weekday and 
a weekend day by examining the roles of sex, anx-
iety, depression, and lung function as predictors of 
adherence. Adherence was measured utilising the 
DPD methodology. It was hypothesised that report-
ed adherence would be higher during the weekend 
in comparison to weekdays, due to it being expected 
that the time pressures are less for adults during the 
weekend (Bregnballe et al., 2011; McNamara et al., 
2009; Latchford et al., 2009). 
ParticiPants and Procedure 
Study deSign
A  within-participants design was utilised to com-
pare the adherence of individuals with CF during the 
weekend in comparison to weekdays.
RecRuitment
Fifty-two participants (27 females, 25 males), who 
were all adult patients aged 18-54 years (M = 29.59 
years, SD = 10.01) were recruited at the West Mid-
lands Adult Cystic Fibrosis Centre. Eligibility criteria 
included: 1) having the capacity to decide upon one’s 
participation (identified by the patient’s consultant) 
2) being an outpatient 3) English speaking. Opportuni-
ty sampling was utilised by inviting patients attending 
clinics to participate in this study. In total, 71 patients 
were approached and invited to participate; 19 pa- 
tients refused participation. Patients gave a  variety 
of reasons for not participating, which included time 
restrictions, negative affect and phone calls not being 
suitable. Once informed consent had been established, 
participants completed the Hospital Anxiety and De-
pression Scale (HADS) (Sundbom & Bingefors, 2013) 
during clinic time. The participant was then contact-
ed on two days (one weekend day and one weekday 
within the next week) via telephone by the researcher, 
recording the number of treatments performed (phys-
iotherapy, pancreatic enzymes, vitamins and exercise), 
in comparison to the number of prescribed treatments, 
to collect their adherence percentage. 
the hoSpital anxiety  
and depReSSion Scale
The HADS (Zigmond &  Snaith, 1983) is a  well-es-
tablished and well-validated screening tool, which is 
short and easy to administer (Backström-Eriksson et 
al., 2015). It is a  fourteen item questionnaire which 
measures symptoms of emotional distress whilst ex-
cluding symptoms which would have derived from 
a physical disorder (Backström-Eriksson et al., 2015). 
The questionnaire has two separate scales, one assess-
ing for anxiety, the other assessing for depression, 
with both scales having good psychometric proper-
ties (mean Cronbach’s α for the anxiety subscale was 
.83 and for the depression subscale was .82) (Bjelland, 
Dahl, Haug, & Neckelmann, 2002). The anxiety and 
depression scales each have seven questions. Partic-
ipants have to indicate the extent to which they do 
or do not perform that task, or feel how described in 
each statement on a  four-point Likert scale, which 
ranges from 0 (not at all) to 3 (most of the time). Scores 
for each scale are categorised as normal (0-7), mild 
(8-10), moderate (11-14) and severe (15-21) (Snaith 
& Zigmond, 2012). In order to analyse the data a me-
dian split was used to separate the groups into “high 
levels of anxiety”, “low levels of anxiety”, and “high 
levels of depression”, “low levels of depression”. 
daily phone diaRy
The DPD methodology uses a  day reconstruction 
method (Kahneman, Krueger, Schkade, Schwarz, 
& Stone, 2004) attempting to reduce memory and re-
call issues which are associated with questionnaires 
(Modi & Quittner, 2006). The cued recall procedure 
used within this method (asking participants to re-
port all activities that have occurred within the past 
twenty-four hours) is believed to result in an increase 
in participants reporting actual behaviours, rather 
than estimates (Modi et al., 2006). Previous research 
has shown that the DPD methodology reduces the 
occurrence of memory decay and decreases the 
likelihood of social desirability bias, as it is difficult 
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for participants to report an activity which did not 
happen when they are tracked through twenty-four 
hours (Quittner, Modi, Lemanek, Ievers-Landis, 
&  Rapoff, 2008). Quittner, DiGirolamo, Michel, and 
Eigen (1992) reported that within a CF population the 
DPD methodology “yielded reliable stability coeffi-
cients over a  three week period (r values = .61-.71, 
p = .010) along with high levels of inter-rater reliabil-
ity (> 90.00%)” (Modi & Quittner, 2006, p. 6). DPDs 
can also identify barriers to adherence, due to partic-
ipants recording all activities they have engaged in, 
not just their medical regimens (Quittner et al., 2008). 
Finally, it is reported that DPDs are an unobtrusive 
adherence measure, with patients often forgetting 
that medical regimens are the focus of the report, as 
all activities during a twenty-four hour period are re-
corded (Modi et al., 2006). 
The DPDs (Modi et al., 2006) were used to collect 
data on participants’ adherence to their medical reg-
imens. Cystic fibrosis daily medical regimens vary 
amongst patients; therefore the researcher reordered 
each participant’s prescribed daily regimens for pan-
creatic enzymes, vitamins, chest physiotherapy and 
exercise (see Table 1). The researcher utilised pa-
tients’ hospital records for the description of what 
was prescribed or recommended by their clinicians 
for each of the four treatment types. Despite CF pa-
tients having to adhere to a range of other import-
ant treatments, this research only investigated ad-
herence to the four treatment types investigated by 
Abbott et al. (1994) in order to emulate this research 
using a DPD rather than questionnaires to measure 
adherence. The DPDs tracked participants through 
the activities they engaged in over the past twen-
ty-four hours to record their adherence to pancre-
atic enzymes, vitamins, physiotherapy and exercise, 
by using a  day reconstruction method (Kahneman 
et al., 2004), accompanied by a cued recall procedure. 
The phone calls were initiated by the researcher, who 
assisted the participant in accurately reconstructing 
their day by providing prompts (Modi et al., 2006) (see 
Table 2). Each activity was recorded by the research-
er on a computer, using Windows FileMaker, indicat-
ing a  twenty-four hour day. Participants completed 
two DPDs (one weekday and one weekend day with 
a  maximum five-day interval between DPDs), each 
requiring a maximum of twenty minutes to complete. 
It was not expected that participants would experi-
ence a sick period during these two time periods due 
to being recruited at their CF outpatient appointment 
after their health status had been assessed. The aims 
of the research were not disclosed to participants, 
so they were not aware that the research was com-
paring weekday and weekend adherence; however, 
they were aware that the research was investigating 
rates of adherence amongst CF patients. An adher-
ence percentage was calculated for each participant 
to illustrate their overall adherence, and their adher-
ence to each medical regimen (see Table 3). Due to 
adherence within CF being predominantly patient 
led, it was possible for adherence percentages to be 
above 100.00%, indicating that patients had engaged 
in that medical regimen more than recommended; it 
was only expected that this would happen for phys-
iotherapy (in response to health deteriorations), and 
exercise.
Table 1
Example of the prescribed daily treatments for three participants. This table was created for each participant by 
a medical record review
Participant Pancreatic Enzymes Vitamins Physiotherapy Exercise
1
Breakfast tablets: 6
Lunch tablets: 8
Dinner tablets: 12
Snack tablets: 5
7
10 minutes twice 
a day
60 minutes
2
Breakfast tablets: 8
Lunch tablets: 9
Dinner tablets: 10
Snack tablets: 6
3
15 minutes twice 
a day
60 minutes
3
Breakfast tablets: 3
Lunch tablets: 5
Dinner tablets: 7
Snack tablets: 5
3
15 minutes twice 
a day
30 minutes
Note. Pancreatic enzymes: Required by CF patients who are pancreatic insufficient to aid with digestion; patients are required to 
take these prior to eating. Vitamins: Typically vitamins A, D, E and K are required due to the likely malabsorption of fat soluble 
vitamins in CF patients, particularly those who are pancreatic insufficient. Physiotherapy: Required by CF patients in order to 
reduce the risk of infection and lung damage by preventing thick, sticky mucus in the lungs blocking the airways. Exercise: Re-
quired to assist in the clearance of mucus from the lungs in CF patients and to improve physical bulk and strength.
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medical RecoRdS
Medical records were used to record participants’ 
demographics, most recent spirometry result (forced 
expiratory volume in one second as percentage of 
predicted, FEV
1
% predicted), comorbidities and med-
ications. In order to analyse the data indicating dis-
ease severity a median split was used to separate the 
groups into “high lung function” and “low lung func-
tion”. Participants’ lung function was recorded by 
their health care professionals as part of their clinic 
appointment to provide an indication of their pulmo-
nary function.
StatiStical analySiS
Due to the small sample size, paired-sample t-tests 
were carried out using SPSS 21.0 for Windows.
ethical appRoval
All procedures performed within this research was in 
accordance with the ethical standards of the national 
research committee. Ethical approval was granted by 
NRES Committee East Midlands – Derby. Informed 
consent was obtained from all individual participants 
included in the study.
results
deScRiptive StatiSticS
Participants reported adhering most to exercise, fol-
lowed by pancreatic enzymes, vitamins, and physiother-
apy. The majority of participants did not show evidence 
of anxiety or depression (0-7 = normal) (see Table 4).
Weekend/Weekday compaRiSon  
in adheRence
There was a  significant difference in the scores 
for the weekday physiotherapy and the weekend 
physiotherapy conditions, with participants having 
higher reported adherence to physiotherapy during 
the weekend in comparison to weekdays. Adherence 
to weekend exercise was also reported to be signifi-
Table 2
Sample Daily Phone Diary Schedule in accordance with guidance from Modi et al. (2006)
Sample DPD Interview Schedule
Interviewer: Hello, am I speaking to (Participant number)?
Reply
Interviewer: Thank you, this is Rebecca Keyte, we met at (name of hospital) on (date). Would this be 
a good time for us to complete the phone diary as agreed?
Reply
Interviewer: Thank you. I would like you to report all activities you have engaged in during the past 
24 hours. So what time did you wake up yesterday morning?
Reply
•	 For the remainder of the interview prompts will be used to remind the participant of what activi-
ties they engaged in.
•	 After any mention of food/meals the interviewer will ask: “And how many pancreatic enzymes did 
you take with that?”
•	 If there is no mention of vitamins, at the end of the interview the interviewer will say “Have you 
taken any vitamin tablets during the past twenty-four hours?” Reply; Interviewer “And how many 
of these tablets did you take?”
END:
Interviewer: Thank you for your time to complete this phone diary. The information you have disclosed 
to me is clear; I have no further questions to ask you. Are there any questions you would like to ask me?
Table 3
How participants’ adherence percentages were calculated
How to record adherence percentages (Modi et al., 2006)
Number of treatments performed that day/number prescribed X 100 = % adherence for that day
Overall adherence % = (physiotherapy % adherence + exercise % adherence +  
pancreatic enzymes % adherence + vitamins % adherence)/4
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cantly higher than weekday exercise. There was no 
significant difference between weekday and week-
end adherence to pancreatic enzymes and vitamins, 
but when combining all of the data, there was over-
all better adherence to treatments on weekend days 
compared to weekdays (see Table 5).
Multivariate ANOVA revealed a  statistically sig-
nificant different in adherence to exercise during the 
weekdays in comparison to adherence during the 
weekend, F(92, 90) = 2.02, p < .001; Wilks’ Λ = .012, 
partial η2 = .67. Analysis of each individual dependent 
variable, using a  Bonferroni adjusted α level of .02, 
showed that there was a  significant difference for 
anxiety F(23, 25) = 2.47, p = .015, partial η2 = .69, and 
for depression F(23, 25) = 2.43, p = .016, partial η2 = .69.
Sex diffeRenceS betWeen cyStic fibRoSiS 
patientS’ adheRence
There was a  significant difference for female partici-
pants in the scores for the weekday exercise and the 
weekend exercise conditions, with female participants 
having higher reported adherence to exercise during 
the weekend in comparison to weekdays. There was no 
significant difference between weekday and weekend 
adherence to physiotherapy, pancreatic enzymes or vi-
tamins for females with CF, but when combining all of 
the data for female participants, there was overall better 
adherence to treatments on weekend days compared to 
weekdays (see Table 6). In addition, when combining all 
of the data for male participants, there was no overall 
difference in adherence to treatments during the week-
end in comparison to weekdays (see Table 6). 
anxiety and adheRence
There was a  significant difference for participants 
with low levels of anxiety in the scores for the week-
day vitamin and weekend vitamin conditions, with 
participants having higher reported adherence to vi-
tamins during the weekdays in comparison to week-
ends. There was no significant difference between 
weekday and weekend adherence to physiotherapy, 
exercise or pancreatic enzymes for participants with 
low levels of anxiety (see Table 7). In addition, there 
was a  significant difference for participants with 
high levels of anxiety in the scores for the weekday 
exercise and weekend exercise conditions, with par-
ticipants having higher reported adherence to exer-
cise during the weekend in comparison to weekdays. 
There was no significant difference between weekday 
and weekend adherence to physiotherapy, pancreatic 
enzymes or vitamins for participants with high levels 
of anxiety, but when combining all of the data for 
participants with high levels of anxiety, there was 
overall better adherence to treatments at weekends 
compared to weekdays (see Table 7).
depReSSion and adheRence
There was a  significant difference for participants 
with high levels of depression in the scores for the 
Table 4
Descriptive statistics
Measurements M (SD)
Age 29.59 (10.00)
Anxiety (HAD-A) 5.82 (3.66)
Depression (HAD-D) 3.39 (3.63)
Lung function (FeV1) 56.49% (23.84)
Overall exercise adherence 97.30% (106.43)
Overall pancreatic enzyme 
adherence
93.80% (17.93)
Overall vitamin adherence 85.37% (33.02)
Overall physiotherapy 
adherence
58.89% (66.37)
Table 5
Mean scores and standard deviations as well as mean comparisons for overall adherence during the weekend in 
comparison to weekdays
Weekend/weekday comparison in adherence 
Treatment M (SD) t p η2
Weekday Weekend
Physiotherapy 50.38 (51.74) 67.40 (85.71) –2.42 .019 .11
Exercise 69.42 (104.95) 125.17 (152.49) –2.56 .014 .12
Pancreatic enzyme 93.28 (19.23) 94.32 (17.42) –0.95 .349 –
Vitamin 89.41 (36.77) 80.66 (39.84) 1.56 .124 –
Overall 75.62 (28.37) 89.85 (45.06) –2.19 .034 .09
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weekday physiotherapy and weekend physiotherapy 
conditions, with participants having higher reported 
adherence to physiotherapy during the weekend in 
comparison to weekdays. There was no significant 
difference between weekday and weekend adherence 
to exercise, pancreatic enzymes or vitamins for par-
ticipants with high levels of depression, but when 
combining all of the data for participants with high 
levels of depression, there was overall better adher-
ence to treatments at weekends compared to week-
days (see Table 8).
fev
1
 and adheRence
There was a  significant difference for partici-
pants with a  low lung function in the scores for 
the weekday exercise and weekend exercise con-
Table 6
Mean scores and standard deviations as well as mean comparisons in overall adherence by sex
Weekend/Weekday comparison in adherence by sex
Treatment Weekday Weekend t p η2
Females
Physiotherapy 62.32 (59.32) 82.70 (109.12) –1.68 .107 –
Exercise 59.58 (70.16) 122.92 (125.76) –2.59 .016 .23
Pancreatic enzyme 93.86 (16.21) 96.22 (9.45) –1.17 .255 –
Vitamin 85.85 (28.10) 79.81 (37.85) 0.68 .505 –
Overall 75.41 (22.08) 95.41 (43.15) –2.90 .008 .27
Males
Physiotherapy 38.91 (41.25) 52.71 (53.13) –1.82 .082 .12
Exercise 78.87 (130.86) 127.33 (177.03) –1.34 .192 –
Pancreatic enzyme 92.72 (22.07) 92.51 (22.67) 0.22 .829 –
Vitamin 92.83 (43.85) 81.47 (42.43) 1.63 .117 –
Overall 75.83 (33.79) 84.51 (47.08) –0.79 .435 –
Table 7
Mean scores and standard deviations as well as mean comparisons in overall adherence by levels of anxiety
Anxiety and adherence
Treatment Weekday Weekend t p η2
Low level anxiety
Physiotherapy 50.66 (52.73) 71.56 (94.16) –1.91 .070 .14
Exercise 75.58 (130.86) 125.36 (186.33) –1.30 .207 –
Pancreatic enzyme 90.58 (24.53) 89.73 (24.05) 0.70 .490 –
Vitamin 102.64 (34.16) 83.12 (40.37) 2.43 .024 .21
Overall 79.87 (34.36) 88.09 (55.59) –0.66 .515 –
High level anxiety 
Physiotherapy 50.13 (51.88) 63.72 (79.20) –1.48 .153 –
Exercise 63.97 (77.55) 125.00 (118.72) –2.55 .017 .21
Pancreatic enzyme 95.67 (12.96) 98.39 (6.09) –1.56 .131 –
Vitamin 77.71 (35.58) 78.48 (40.04) –0.10 .918 –
Overall 71.87 (21.78) 91.40 (34.27) –3.53 .002 .33
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ditions, with participants having higher reported 
adherence to exercise on weekend days compared 
to weekdays. There was no significant difference 
between weekday and weekend adherence to 
physiotherapy, pancreatic enzymes or vitamins for 
participants with a  low lung function, but when 
combining all of the data for participants with 
a  low lung function, there was overall better ad-
herence to treatments on weekend days compared 
to weekdays (see Table 9).
discussion
This research shows that CF patients have higher 
reported adherence during the weekend in compari-
son to weekdays; therefore the hypothesis was sup-
ported. The use of the DPD methodology overcomes 
some limitations of other methodologies, which en-
hances the reliability of the findings. 
This weekend/weekday difference in adherence 
was most prevalent within female CF patients, with 
Table 8
Mean scores and standard deviations as well as mean comparisons in overall adherence by levels of depression
Depression and adherence
Treatment Weekday Weekend t p η2
High level depression
Physiotherapy 47.79 (53.07) 73.30 (89.36) –2.29 .032 .19
Exercise 69.78 (105.22) 123.91 (126.51) –1.91 .069 –
Pancreatic enzyme 95.72 (13.59) 97.56 (6.94) –.90 .377 –
Vitamin 81.84 (33.19) 78.41 (42.61) .48 .638 –
Overall 73.78 (27.98) 93.29 (34.85) –2.82 .010 .27
Low level depression
Physiotherapy 52.67 (51.47) 62.18 (83.77) –1.08 .291 –
Exercise 69.10 (106.80) 125.28 (174.81) –1.73 .096 –
Pancreatic enzyme 91.12 (23.18) 91.46 (22.84) –.32 .750 –
Vitamin 96.11 (39.08) 82.65 (37.96) 1.60 .123 –
Overall 77.25 (29.15) 86.80 (53.01) –.89 .380 –
Table 9
Mean scores and standard deviations as well as mean comparisons in overall adherence by disease severity
Lung function (FEV1) and adherence
Treatment Weekday Weekend t p η2
Low lung function
Physiotherapy 68.45 (58.15) 89.95 (104.51) –1.84 .078 –
Exercise 43.78 (55.99) 102.56 (89.40) –3.08 .005 .27
Pancreatic enzyme 94.78 (19.95) 96.15 (19.61) –1.41 .170 –
Vitamin 83.10 (42.67) 76.68 (44.49) 0.75 .463 –
Overall 72.53 (22.60) 91.34 (38.56) –3.34 .003 .31
High lung function
Physiotherapy 29.95 (34.29) 41.91 (48.34) –1.66 .111 –
Exercise 98.41 (137.17) 150.72 (200.91) –1.26 .222 –
Pancreatic enzyme 91.58 (18.67) 92.23 (14.71) –0.32 .753 –
Vitamin 96.55 (27.93) 85.14 (34.26) 1.61 .121 –
Overall 79.12 (33.92) 88.16 (52.30) –0.73 .474 –
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sex, anxiety, depression and lung function being pre-
dictors of adherence. This research therefore supports 
previous work in indicating that an increase in dis-
ease severity has an impact on adherence within CF 
patients (Kettler et al., 2002), as does the occurrence 
of anxiety and/or depression (Hillard et al., 2014). 
In the current research, overall adherence rates 
were higher than expected (83.80%) in comparison to 
previous research which has documented that adher-
ence within CF varies in the range 50.00-70.00% (Ab-
bott et al., 1994; McNamara et al., 2009). However, the 
overall adherence in the current research could have 
been influenced by social desirability bias, which 
if present would have inflated participants’ rates 
of adherence. For instance, the interview approach 
involved the use of prompts; in particular, if a par-
ticipant did not mention adherence to vitamin treat-
ments, the researcher would specifically ask whether 
any vitamins were taken during that day, rather than 
assuming non-adherence based on the lack of report. 
In line with previous research, the results of the cur-
rent research indicate that adherence differs between 
treatment types (Abbott et al., 1994; O’Donohoe et al., 
2014). However, in the current research adherence was 
highest for pancreatic enzymes and vitamins, whereas 
Abbott et al. (1994) reported that adherence was high-
est for pancreatic enzymes and exercise. Abbott et al. 
(1994) hypothesised that adherence was influenced by 
the short-term benefits of treatment. However, the re-
sults from the current research indicate that a patient’s 
adherence may be influenced by the time it takes to 
complete a particular treatment, with physiotherapy 
and exercise requiring more time from a patient than 
pancreatic enzyme and vitamin treatments.
The results of the current research differ from 
those of Ball et al. (2013), who found that reported 
adherence in a cohort of paediatric CF patients was 
significantly higher on weekdays compared to week-
ends. Due to the current research using a different 
method to Ball et al. (2013) in order to record rates 
of adherence, this difference in findings provides 
a  suggestion for future research, to investigate the 
adherence relationship between paediatric and adult 
CF patients using the same method, whether that is 
the DPD methodology or an objective time and date 
stamped nebuliser. 
It is plausible that adult patients experience dif-
ficulty adhering to treatments during the weekdays 
due to patients experiencing an increase in respon-
sibility for their own medical regimens as they enter 
adulthood, with parents/guardians no longer having 
as much control of their treatments. This may result 
in CF patients finding it more challenging to inde-
pendently integrate their daily treatments within 
their weekday lifestyle alongside other life commit-
ments. Bregnballe et al. (2011) support this assertion, 
indicating that one of the main adherence barriers is 
a lack of time. 
It may also be the case that CF adolescents and 
adults are consciously choosing to be non-adherent 
during the weekdays in an attempt to hide their ill-
ness from their peers. All patients have illness cog-
nitions to provide themselves with a framework for 
coping and understanding their illness (Leventhal, 
Weinman, Leventhal, & Phillips, 2007); one cognitive 
dimension of these beliefs is identity. It is possible 
that CF patients do not adhere to their medical regi-
mens in front of their peers during the weekdays (e.g. 
at college/university/work) in order to hide their ill-
ness, and this is being further examined by the au-
thors in a follow-up study. 
Indeed, an important concept within identity is 
image, with Yates et al. (2010) suggesting that many 
chronically ill individuals favour a  degree of invis-
ibility towards their illness, allowing them greater 
normalcy. In terms of CF, patients can often appear 
to be “physically normal” as CF is a relatively invis-
ible impairment (Tierney, 2012). However, patients 
may feel that their illness is on display when they 
have to engage in medical regimens (e.g. taking tab-
lets in public), and therefore some CF patients may 
consciously choose to be non-adherent to uphold this 
sense of invisibility (Withers, 2012). Bregnballe et al. 
(2001) indicated that one of the main adherence bar-
riers in CF is unwillingness to take medications in 
public.
The role of identity could explain why the week-
end/weekday difference in adherence was most prev-
alent in adult female CF patients. Patterson et al. 
(2008) demonstrated that female adolescents with CF 
display more non-adherent behaviours in compar-
ison to male adolescents with CF. In particular, fe-
males were more likely to experience embarrassment 
when coughing and taking CF medications. There-
fore female CF patients may have lower reported ad-
herence during the weekdays due to their conscious 
efforts to avoid following their medical regimens in 
front of their peers (at college/university/work), in 
order to provide themselves with a normal identity 
that does not highlight their CF. Further research 
which demonstrates that female CF patients prefer 
a  sense of invisibility to their illness comes from 
Higham et al. (2013). They found that in order to be 
perceived as normal, many female CF patients hide 
their illness from their partners, with the majority 
of female CF patients only disclosing their illness to 
their partner when they believe their relationship is 
going to be long-term. 
Interestingly, this research found DPDs to be an 
effective technique in highlighting adherence barri-
ers. These barriers were not recorded in the results of 
the present study due to this study following a posi-
tivist approach; however, these barriers provide a ra-
tionale for adherence within CF to be investigated 
using qualitative measures, to provide an in-depth 
insight into barriers and enablers to adherence with-
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in the CF population. For example, one participant 
disclosed that they were concerned that they were 
always prescribed the same antibiotics, and they 
were concerned that their antibiotics were no longer 
effective. This participant had contacted “Facebook 
groups” in which CF patients were voicing their con-
cerns that the limited range of antibiotics available to 
them was resulting in the antibiotics no longer being 
as effective in treating their lung disease. As patients 
have become more active in seeking information 
regarding antibiotic use outside of clinical advice 
(Harris, Sillence, & Briggs, 2011; Scanfeld, Scanfeld, 
& Larson, 2010) the increasing life expectancy in CF 
is creating new challenges in successively treating 
the disease. Patients’ concerns may also be exacer-
bated due to campaigns in the United Kingdom sur-
rounding antibiotic safety. Qualitative research could 
usefully investigate the impact such campaigns have 
on people with long-term conditions.
Several limitations of this study are acknowledged, 
each of which suggests important future directions. 
First, the small sample size was problematic, as it re-
stricted the analyses that could project a high power. 
In addition, while the researchers acknowledge the 
methodological limitations of dichotomization and 
are aware that methodological literature favours the 
use of regressional methods on undichotomized vari-
ables (MacCallum, Zhang, Preacher, & Rucker, 2002), 
the latest research indicates that potential loss of in-
formation or the possibility of a type I error (MacCal-
lum et al., 2002) is not always true. In fact, Iacobucci 
et al. (2015) suggested that there could be analytical 
integrity to dichotomized variables, and that the par-
simonious nature of median splits may well be a pre-
ferred option. While the arguments and critiques still 
continue in the field of dichotomising continuous 
variables (Rucker, McShane, & Preacher, 2015), and 
data continue to emerge with the main analyses cen-
tring on dichotomized variables, we suggest that fu-
ture research with larger sample sizes from multiple 
CF sites are required to support current findings. 
Other potential limitations may relate to the un-
derestimation of how many CF patients experience 
psychological distress (in particular depression), as 
some research indicates that the HADS is poten-
tially insensitive as it does not detect as many cases 
of depression as the Patient Health Questionnaire 
(PHQ-9) (Hansson, Nordstom, &  Bodlund, 2009). 
The researcher did not have any prior knowledge 
regarding participants’ psychological health. Whilst 
it is acknowledged that individuals suffering from 
depression are less likely to participate in research, 
only three out of the nineteen patients who refused 
participation explained that this was due to a nega-
tive affect. Also, the time pressure was taken as giv-
en, based on previous findings, but may well relate to 
other psychosocial factors such as employment sta-
tus and other family commitments (e.g., Taylor-Rob-
inson, Smyth, Diggle, &  Whitehead, 2013), which 
should be explored in future research. In addition, 
whilst this research aimed to emulate that of Abbott 
et al. (1994) in investigating how adherence differs 
between pancreatic enzymes, vitamins, physiother-
apy and exercise, the fact that this research did not 
investigate adherence to respiratory medications is 
a limitation, with further research being required to 
investigate how adherence to respiratory medica-
tions varies during the weekend and weekdays.
To advance the current research and investigate 
more fully the changes in adherence patterns during 
the transition from paediatric to adult care, quali-
tative research is required. We are therefore in the 
process of conducting qualitative interviews with 
CF patients to investigate the relationship between 
health beliefs and health behaviours within the CF 
population, which will increase understanding of 
why some patients have poor adherence to their 
medical regimens, especially during the weekdays. 
Personal identity, levels of acceptance and managing 
CF as an adult are some of the themes currently be-
ing explored. The results of this research will identify 
specific personal barriers to adherence and inform 
interventions aimed at reducing these barriers and 
improve treatment adherence within the CF popula-
tion. 
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